• 1
    Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 2000; 46: 20272049.
  • 2
    Kim H, Nam C, Jee S, Han K, Oh D, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver disease: prospective cohort study. BMJ 2004; 328: 983
  • 3
    Kim WR, Benson JT, Therneau TM, Buritt MF, Melton LJ. Serum aminotransferase activity and risk of mortality in a U. S. community population. HEPATOLOGY 2008; 47; 880887.
  • 4
    Ioannou G, Weiss N, Boyko E, Mozaffarian D. Elevated serum alanine aminotransferase activity and calculated risk of coronary artery disease in the United States. HEPATOLOGY 2006; 43: 11451151.
  • 5
    Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC; Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. HEPATOLOGY 2008; 47: 13631373.
  • 6
    Horowitz GL, Altaie A, Boyd JC, Ceriotto F, Garg U, Horn P, et al. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition. Clinical and Laboratory Standards Institute C28–A3, volume 28(30), 2008.
  • 7
    Neuschwander-Tetri BA, Unalp A, Creer MH, Nonalcoholic steatohepatitis Clinical Research Network. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med 2008; 24: 663666.